metastatic renal cell carcinoma

Showing 1 - 25 of 152

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Renal Cell Carcinoma, Brain Metastases Trial in United States (drug, device, radiation)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Brain Metastases
  • Basking Ridge, New Jersey
  • +6 more
Nov 10, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Computed Tomography, Magnetic Resonance Imaging,

Not yet recruiting
  • Metastatic Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer AJCC v8
  • Computed Tomography
  • +4 more
  • (no location specified)
May 8, 2023

Learn About First and Later Lines of Medicines in Treating

Completed
  • Metastatic Renal Cell Carcinoma
    • New York, New York
      Pfizer Headquarters
    May 12, 2023

    Metastatic Renal Cell Carcinoma Trial in Italy (Axitinib, Nivolumab)

    Not yet recruiting
    • Metastatic Renal Cell Carcinoma
    • Brescia, Italy
    • +22 more
    Apr 19, 2023

    Metastatic Renal Cell Carcinoma Trial in Shanghai (sunitinib or pazopanib, PD-1 inhibitor combined with axitinib)

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • sunitinib or pazopanib
    • PD-1 inhibitor combined with axitinib
    • Shanghai, Shanghai, China
      Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
    Apr 16, 2023

    Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)

    Not yet recruiting
    • Prostate Cancer
    • +11 more
    • Guided physical exercise
    • +2 more
    • Tampere, Länsi-Suomi, Finland
      Tampere University Hospital
    Apr 3, 2023

    Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

    Recruiting
    • Advanced Ovarian Carcinoma
    • +7 more
    • Bydgoszcz, Kujawsko-pomorskie, Poland
    • +2 more
    Mar 7, 2023

    Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)

    Active, not recruiting
    • Metastatic Renal Cell Carcinoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jan 25, 2023

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

    Not yet recruiting
    • Renal Cell Carcinoma
    • +2 more
    • Implantable Microdevice (IMD)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 17, 2023

    Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

    Recruiting
    • Metastatic Kidney Medullary Carcinoma
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +12 more
    • Tucson, Arizona
    • +60 more
    Jan 11, 2023

    Immunophenotyping in Metastatic Kidney Cancer Patients Receiving

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • Stage IV Renal Cell Cancer AJCC v8
    • Biospecimen Collection
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2023

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

    Active, not recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +20 more
    • Pembrolizumab
    • Ziv-Aflibercept
    • Tampa, Florida
    • +8 more
    Jan 3, 2023

    Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

    Active, not recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +35 more
    • Cabozantinib S-malate
    • +2 more
    • Duarte, California
    • +7 more
    Jan 3, 2023

    Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v7 Trial in Canada, Israel,

    Active, not recruiting
    • Metastatic Renal Cell Carcinoma
    • +4 more
    • Nephrectomy
    • +4 more
    • Birmingham, Alabama
    • +414 more
    Dec 30, 2022

    Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +28 more
    • Conroe, Texas
    • +4 more
    Dec 5, 2022

    Metastatic Renal Cell Carcinoma Trial in France (Cabozantinib)

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • Angers, France
    • +8 more
    Dec 5, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

    Recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +11 more
    • Cabozantinib S-malate
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

    Recruiting
    • ccRCC
    • +9 more
    • Oral NKT2152
    • Scottsdale, Arizona
    • +6 more
    Oct 17, 2022

    Advanced Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Duarte (Clostridium

    Active, not recruiting
    • Advanced Renal Cell Carcinoma
    • +5 more
    • Clostridium butyricum CBM 588 Probiotic Strain
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Oct 12, 2022

    Database to prospectivelY aSSEss Changing TherapY Landscape in

    Recruiting
    • Metastatic Renal Cell Carcinoma
      • Iowa City, Iowa
      • +7 more
      Oct 13, 2022

      Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Stage III Renal

      Recruiting
      • Metastatic Renal Cell Carcinoma
      • +4 more
      • Birmingham, Alabama
      • +255 more
      Aug 24, 2022

      Metastatic Renal Cell Carcinoma Trial in United Kingdom (Cyclophosphamide 50mg, Pembrolizumab 25 mg/1 ML Intravenous Solution

      Recruiting
      • Metastatic Renal Cell Carcinoma
      • Cyclophosphamide 50mg
      • Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]
      • Cambridge, United Kingdom
      • +3 more
      Aug 22, 2022

      Metastatic Melanoma, Advanced Locoregional Melanoma, Metastatic Renal Cell Carcinoma Trial run by the National Cancer Institute

      Recruiting
      • Metastatic Melanoma
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 20, 2022